Related Experiment Videos
Why study third-, fourth-, fifth-, ...line chemotherapy of ovarian cancer?
Gynecologic Oncology
|December 6, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.
Annales de cardiologie et d'angeiologie·2021
Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.
European journal of gynaecological oncology·2018
Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
Current oncology (Toronto, Ont.)·2018
Surgical intervention in relapsed ovarian cancer is beneficial: contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Planning and feasibility of phase III surgical trials in gynecologic oncology.
Gynecologic oncology·2026
Molecular characterization of NSMP endometrial cancer and its relevance for treatment.
Gynecologic oncology·2026
Constructing an in vitro choriocarcinoma model by three-dimensional bioprinting.
Translational cancer research·2026
Schisandrin C Targets PPARγ to Induce Ferroptosis in Colorectal Cancer Cells and Promote M1 Macrophage Polarization.
Phytotherapy research : PTR·2026
Platinum chemotherapy ages the liver.
Science (New York, N.Y.)·2026